BNET Industries

Mylan Technologies Inc.

is in the Manufacturing Industry

Last Fiscal Year Sales:$37.5M
  • Private
Dow Jones Description

Mylan Technologies Inc. (MTI) is a member of the Mylan family of companies. We are dedicated to the design, development and manufacture of transdermal drug delivery systems. We have developed a variety of generic transdermal products available for the U.S. market. MTI was the first company to receive approval for generic Nitroglycerin, Estradiol and Fentanyl transdermal systems. Our scientists also aided in the development of EMSAM (selegiline transdermal system). And today, EMSAM is manufactured by MTI. Mylan Technologies Inc. also produces components for the medical device and transdermal industries. Our unmatched expertise, reputation for exceptional quality and ability to develop components are a catalyst for innovative and proprietary healthcare products.

Number of Employees 420
Contact Information

www.mylantech.c...

NAICS Code Coated and Laminated Packaging Paper Manufacturing: 322221

News & Analysis

mylan technologies inc. - All News and Analysis

  • Mylan Technologies

    - 2005-03-07

    The FDA granted approval to Mylan Technologies for the first generic version of Alza's Duragesic Patch fentanyl transdermal system for the treatment of severe chronic pain that cannot be managed with alternate analgesics. When applied to the skin, the patch technology delivers fentanyl, an opioid pain medication absorbed into the...

    Tags: Mylan Technologies Inc.

  • Able wins okay to market metronidazole capsules

    - 2003-12-15

    WASHINGTON -- Able Laboratories Inc. has received Food and Drug Administration approval for metronidazole capsules, 375-mg. The product is therapeutically equivalent to Flagyl capsules of the same strength manufactured by G.D. Searle LLC. According to Able, the total market for its newly approved product, used in the treatment...

    Tags: Mylan Technologies Inc.

  • Mylan ads honored; govil to head mylan technologies

    - 2001-11-19

    The Rx Club, the creative organization that recognizes the best in pharmaceutical advertising and promotional campaigns, chose generic maker Mylan as the winner in three of its award categories. Mylan's 40th Anniversary Book took top honors in the "Special Projects" category, its "Bright Past, Shining Future" journal advertisement took the...

    Tags: Mylan Technologies Inc.

  • Mylan Names Sharad K. Govil President of Mylan Technologies Inc

    - 2001-10-02

    Business Editors PITTSBURGH--BUSINESS WIRE--Oct. 2, 2001 Mylan Laboratories Inc. (NYSE:MYL) announced today that Sharad K. Govil, Ph.D., has been named president of Mylan Technologies Inc. Dr. Govil will be responsible for the development, manufacturing and international business development of Mylan Technologies' drug delivery systems and components business....

    Tags: Mylan Technologies Inc.

Decision Makers

Name (plus bio) Position
Sharad K. Garil President
John Hango Vice President Operations
Joyce Campbell Manager, Manufacturing

Organization Position Status
Mylan Technologies, Incorporated President Current

Organization Position Status
Mylan Technologies, Incorporated Vice President Operations Current

Organization Position Status
Mylan Technologies, Incorporated Manager, Manufacturing Current